A Study of SI-B036 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

NCT07744243 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Urological Cancer
Solid Cancer

Interventions

DRUG: SI-B036

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]